NEW YORK, Oct. 29, 2019 (GLOBE NEWSWIRE) -- Levi & Korsinsky, LLP announces that class action lawsuits have commenced on behalf of shareholders of the following publicly-traded companies. Shareholders interested in serving as lead plaintiff have until the deadlines listed to petition the court and further details about the cases can be found at the links provided. There is no cost or obligation to you.

Altria Group, Inc. (NYSE: MO)
Class Period: December 20, 2018 - September 24, 2019
Lead Plaintiff Deadline: December 2, 2019
Join the action: https://www.zlk.com/pslra-1/altria-group-inc-loss-form?wire=3 

The lawsuit alleges: Altria Group, Inc. made materially false and/or misleading statements throughout the class period and/or failed to disclose that: (i) Altria had conducted insufficient due diligence into JUUL prior to the Company’s $12.8 billion investment, or 35% stake, in JUUL; (ii) Altria consequently failed to inform investors, or account for, material risks associated with JUUL’s products and marketing practices, and the true value of JUUL and its products; (iii) all of the foregoing, as well as mounting public scrutiny, negative publicity, and governmental pressure on e-vapor products and JUUL made it reasonably likely that Altria’s investment in JUUL would have a material negative impact on the Company’s reputation and operations; and (iv) as a result, the Company’s public statements were materially false and misleading at all relevant times.

To learn more about the Altria Group, Inc. class action contact jlevi@levikorsinsky.com.

Covetrus, Inc. (NASDAQ: CVET)
Class Period: February 8, 2019 - August 12, 2019
Lead Plaintiff Deadline: November 29, 2019
Join the action: https://www.zlk.com/pslra-1/covetrus-inc-loss-form?wire=3 

The lawsuit alleges: Covetrus, Inc. made materially false and/or misleading statements and/or failed to disclose that: (i) the Company had overstated its capabilities with regard to inventory management and supply chain services; (ii) Covetrus had understated the costs of the integration of Henry Schein’s Animal Health Business and VFC, including the timing and nature of those costs; (iii) Covetrus had understated its separation costs from Henry Schein; and (iv) the Company understated the impact on earnings from online competition and alternative distribution channels as well as the impact of the loss of a large customer in North America just prior to the Company’s separation from Henry Schein.

To learn more about the Covetrus, Inc. class action contact jlevi@levikorsinsky.com.

The Chemours Company (NYSE: CC)
Class Period: February 16, 2017 - August 1, 2019
Lead Plaintiff Deadline: December 9, 2019
Join the action: https://www.zlk.com/pslra-1/the-chemours-company-loss-form?wire=3 

The lawsuit alleges that, during the class period, The Chemours Company made materially false and/or misleading statements and/or failed to disclose that: (1) Chemours had not appropriately accounted and accrued reserves for its environmental liabilities; (2) the possibility of costs exceeding accrued amounts was greater than the Company had represented to a point that could be material; (3) the Company's policies, standards and procedures were not properly designed to prevent unreasonable risk of harm to people and the environment (4) Chemours'  handling, manufacture, use, and disposal of hazardous substances was not in accordance with applicable environmental laws and regulations; and (5) as a result of these misrepresentations, Chemours shares traded at artificially inflated prices.

To learn more about the The Chemours Company class action contact jlevi@levikorsinsky.com.

Pareteum Corporation (NASDAQ: TEUM)
Class Period: December 14, 2017 - October 21, 2019
Lead Plaintiff Deadline: December 23, 2019
Join the action: https://www.zlk.com/pslra-1/pareteum-corporation-loss-form?wire=3 

The lawsuit alleges: Pareteum Corporation made materially false and/or misleading statements throughout the class period and/or failed to disclose that: (a) it  was  not  true  that  the  Company’s  purported success was the result of hyper-demand for Pareteum’s unique products or exceptional service,  or  the  Company’s  competent  management;  but,  in  fact,  Defendants  had  propped  up  the  Company’s  results  by  manipulating  Pareteum’s  accounting  for  revenues, income, and the important Backlog metric; (b) Defendants had  materially  overstated  the  Company’s  profitability  by  failing  to  properly  account  for  the  Company’s results of operations and by artificially inflating the Company’s financial results; (c) it was not true that Pareteum contained even the most minimally adequate systems of internal operational or financial controls necessary to assure that Pareteum’s reported financial statements were true, accurate, and/or reliable; (d) as a result, it also was not true that the Company’s financial statements and reports were prepared in accordance with GAAP and SEC rules; and (e) as  a  result  of  the  aforementioned  adverse  conditions, Defendants lacked any reasonable basis to claim that  Pareteum  was  operating  according  to  plan,  or  that  Pareteum  could  achieve  the  guidance  sponsored and/or endorsed by Defendants.

To learn more about the Pareteum Corporation class action contact jlevi@levikorsinsky.com.

You have until the lead plaintiff deadlines to request the court appoint you as lead plaintiff. Your ability to share in any recovery doesn’t require that you serve as a lead plaintiff.

Levi & Korsinsky is a national firm with offices in New York, California, Connecticut, and Washington D.C. The firm’s attorneys have extensive expertise and experience representing investors in securities litigation and have recovered hundreds of millions of dollars for aggrieved shareholders. Attorney advertising. Prior results do not guarantee similar outcomes.

CONTACT:
Levi & Korsinsky, LLP
Joseph E. Levi, Esq.
55 Broadway, 10th Floor
New York, NY 10006
jlevi@levikorsinsky.com
Tel: (212) 363-7500
Fax: (212) 363-7171
www.zlk.com